Evidence map›Paper›PMID 37272871›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2023

Th1 Cells Alter the Inflammatory Signature of IL-6 by Channeling STAT Transcription Factors to Alu-like Retroelements.

David Millrine, Ana Cardus Figueras, Javier Uceda Fernandez, Robert Andrews, Barbara Szomolay, Benjamin C Cossins, Christopher M Rice, Jasmine Li, Victoria J Tyrrell, Louise McLeod and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 5 countries.

David MillrineDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom.
Ana Cardus FiguerasDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom.ORCID 0000-0003-4699-6205
Javier Uceda FernandezDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom.
Robert AndrewsDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom.ORCID 0000-0002-3491-2361
Barbara SzomolayDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom.
Benjamin C CossinsDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom.
Christopher M RiceSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.ORCID 0000-0002-8158-4022
Jasmine LiDepartment of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Victoria J TyrrellDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom.ORCID 0000-0002-2987-118X
Louise McLeodCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.ORCID 0000-0002-7595-6432
Peter HolmansDivision of Psychological Medicine and Clinical Neuroscience, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom.
Valerie B O'DonnellDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom.
Philip R TaylorDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom.ORCID 0000-0003-0163-1421
Stephen J TurnerDepartment of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.ORCID 0000-0002-1002-0000
Brendan J JenkinsCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
Gareth W JonesSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.ORCID 0000-0002-0125-4841
Nicholas TopleyDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom.ORCID 0000-0003-2925-4779
Nigel M WilliamsDivision of Psychological Medicine and Clinical Neuroscience, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom.
Simon A JonesDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom.ORCID 0000-0001-7297-9711
University of Wales Institute Cardiff · SGCardiff University · GBDiscovery Institute · USHudson Institute of Medical Research · AUUniversity of Bristol · GBUK Dementia Research Institute · GBUniversity of Dundee · GB

Funding

Medical Research Council MR/L010305/1Medical Research Council MR/X00077X/1Versus Arthritis 19796Versus Arthritis 20305Versus Arthritis 20770Wellcome Trust 107964
6 · The paper itself

Abstract

Cytokines that signal via STAT1 and STAT3 transcription factors instruct decisions affecting tissue homeostasis, antimicrobial host defense, and inflammation-induced tissue injury. To understand the coordination of these activities, we applied RNA sequencing, chromatin immunoprecipitation sequencing, and assay for transposase-accessible chromatin with high-throughput sequencing to identify the transcriptional output of STAT1 and STAT3 in peritoneal tissues from mice during acute resolving inflammation and inflammation primed to drive fibrosis. Bioinformatics focused on the transcriptional signature of the immunomodulatory cytokine IL-6 in both settings and examined how profibrotic IFN-γ-secreting CD4+ T cells altered the interpretation of STAT1 and STAT3 cytokine cues. In resolving inflammation, STAT1 and STAT3 cooperated to drive stromal gene expression affecting antimicrobial immunity and tissue homeostasis. The introduction of IFN-γ-secreting CD4+ T cells altered this transcriptional program and channeled STAT1 and STAT3 to a previously latent IFN-γ activation site motif in Alu-like elements. STAT1 and STAT3 binding to this conserved sequence revealed evidence of reciprocal cross-regulation and gene signatures relevant to pathophysiology. Thus, we propose that effector T cells retune the transcriptional output of IL-6 by shaping a regulatory interplay between STAT1 and STAT3 in inflammation.

Indexed as

Interleukin-6Th1 CellsAnimalsCytokinesInflammationMiceRetroelementsSTAT1 Transcription FactorSTAT3 Transcription FactorSTAT Transcription FactorsCytokinesInterleukin-6RetroelementsSTAT1 Transcription FactorSTAT3 Transcription FactorSTAT Transcription Factors

Identifiers

PMID37272871
PMCPMC10315439
OpenAlexW4379375635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.